Recently, the reputable intellectual property magazine Asia IP released its China IP Awards 2022, announcing the winning Chinese law firms in each practice area.
AFD China, by virtue of its outstanding IP expertise in the fields of pharma, biotech and life sciences as well as its timely, high-quality and targeted services offered to the clients, was once again honored by Asia IP as "Pharma, Biotech & Life Sciences Firms of the Year".
The China IP Awards are designed to honor outstanding law firms with presence in China for their high-standard services in trademark, patent and copyright work. To determine the winning firms, Asia IP's editorial team will evaluate each firm' performance in the preceding 12 months in IP-related fields, especially their most important cases, and analyze their influence in and contribution to the IP industry, in conjunction with feedback and recommendations received from IP professionals from around the world.
We can never win this award without our clients' trust and support or our colleagues' strict implementation of our firm's working regulations. We will continue to put clients' interests in the first place, take clients' satisfaction as the starting point and final goal of our work, and strive to safeguard clients' intangible IP assets with professional service and sincere attitude.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.